Related Experiment Video
Updated: Apr 7, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis and Evaluation of New Podophyllotoxin Derivatives with in Vitro Anticancer Activity
Wei-Hua Cheng1, Hai Shang2, Cong Niu3
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China. cheng1083@163.com.
Abstract:
A series of novel podophyllotoxin derivatives were designed and synthesized. The cytotoxic activities of these compounds were tested against three tumor cell lines (HeLa, K562, and K562/A02). Most of the derivatives (IC50 = 1-20 μM) were found to have stronger cell growth inhibitory activity than positive control etoposide. Among them, 4β-N-[(E)-(5-((4-(4-nitrophenyl)-piperazin-1-yl)methyl)furan-2-yl)prop-2-en-1-amine]-4-desoxy-podophyllotoxin (9l) demonstrated significant inhibitory activity against HeLa, K562, and K562/A02 cell lines with IC50 values of 7.93, 6.42, 6.89 μM, respectively.
Insights
Novel podophyllotoxin derivatives show potent anticancer activity. Compound 9l exhibits significant cytotoxic effects against HeLa, K562, and K562/A02 tumor cell lines, outperforming etoposide.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Research
Background:
- Podophyllotoxin is a natural product with known anticancer properties.
- Developing novel derivatives can enhance efficacy and overcome resistance.
- Tumor cell lines like HeLa, K562, and K562/A02 are standard models for evaluating cytotoxic agents.
Purpose of the Study:
- To design and synthesize new podophyllotoxin derivatives.
- To evaluate the cytotoxic activity of these novel compounds against various cancer cell lines.
- To identify lead compounds with improved anticancer potential.
Main Methods:
- Chemical synthesis of a series of novel podophyllotoxin derivatives.
- In vitro cytotoxic assays using HeLa, K562, and K562/A02 cell lines.
- Determination of half-maximal inhibitory concentration (IC50) values.
Main Results:
- Most synthesized derivatives displayed enhanced cell growth inhibitory activity compared to etoposide.
- Compound 9l, specifically 4β-N-[(E)-(5-((4-(4-nitrophenyl)-piperazin-1-yl)methyl)furan-2-yl)prop-2-en-1-amine]-4-desoxy-podophyllotoxin, showed potent activity.
- Compound 9l achieved IC50 values of 7.93 μM (HeLa), 6.42 μM (K562), and 6.89 μM (K562/A02).
Conclusions:
- The novel podophyllotoxin derivatives possess significant cytotoxic potential.
- Compound 9l is a promising candidate for further investigation as an anticancer agent.
- These findings support the development of podophyllotoxin analogs for cancer therapy.
